Annual CFO
$14.46 B
+$222.00 M+1.56%
31 December 2023
Summary:
Novartis AG annual cash flow from operations is currently $14.46 billion, with the most recent change of +$222.00 million (+1.56%) on 31 December 2023. During the last 3 years, it has risen by +$808.00 million (+5.92%). NVS annual CFO is now -4.07% below its all-time high of $15.07 billion, reached on 31 December 2021.NVS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$6.29 B
+$1.41 B+28.94%
30 September 2024
Summary:
Novartis AG quarterly cash flow from operations is currently $6.29 billion, with the most recent change of +$1.41 billion (+28.94%) on 30 September 2024. Over the past year, it has increased by +$908.00 million (+16.88%). NVS quarterly CFO is now -38.31% below its all-time high of $10.19 billion, reached on 30 September 2007.NVS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$15.97 B
+$908.00 M+6.03%
30 September 2024
Summary:
Novartis AG TTM cash flow from operations is currently $15.97 billion, with the most recent change of +$908.00 million (+6.03%) on 30 September 2024. Over the past year, it has dropped by -$49.00 million (-0.31%). NVS TTM CFO is now -0.75% below its all-time high of $16.09 billion, reached on 30 September 2007.NVS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.6% | +16.9% | -0.3% |
| 3 y3 years | +5.9% | +27.6% | +5.1% |
| 5 y5 years | +1.3% | +37.8% | +15.3% |
NVS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.1% | +5.9% | at high | +281.2% | -0.3% | +16.0% |
| 5 y | 5 years | -4.1% | +6.1% | at high | +281.2% | -0.3% | +21.1% |
| alltime | all time | -4.1% | +239.9% | -38.3% | +225.3% | -0.8% | +931.9% |
Novartis AG Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.29 B(+28.9%) | $15.97 B(+6.0%) |
| June 2024 | - | $4.88 B(+115.2%) | $15.06 B(+9.4%) |
| Mar 2024 | - | $2.27 B(-11.1%) | $13.77 B(-4.8%) |
| Dec 2023 | $14.46 B(+1.6%) | $2.55 B(-52.6%) | $14.46 B(-9.8%) |
| Sept 2023 | - | $5.38 B(+50.4%) | $16.02 B(+4.3%) |
| June 2023 | - | $3.58 B(+20.9%) | $15.37 B(-1.2%) |
| Mar 2023 | - | $2.96 B(-28.1%) | $15.54 B(+9.2%) |
| Dec 2022 | $14.24 B(-5.5%) | $4.11 B(-12.9%) | $14.24 B(+1.6%) |
| Sept 2022 | - | $4.72 B(+25.7%) | $14.01 B(-1.4%) |
| June 2022 | - | $3.75 B(+127.7%) | $14.21 B(-2.6%) |
| Mar 2022 | - | $1.65 B(-57.5%) | $14.59 B(-3.2%) |
| Dec 2021 | $15.07 B(+10.4%) | $3.88 B(-21.1%) | $15.07 B(-0.8%) |
| Sept 2021 | - | $4.92 B(+19.2%) | $15.19 B(+13.2%) |
| June 2021 | - | $4.13 B(+94.0%) | $13.42 B(+1.3%) |
| Mar 2021 | - | $2.13 B(-46.8%) | $13.25 B(-2.9%) |
| Dec 2020 | $13.65 B(+0.2%) | $4.00 B(+26.9%) | $13.65 B(+3.5%) |
| Sept 2020 | - | $3.16 B(-20.3%) | $13.19 B(-9.6%) |
| June 2020 | - | $3.96 B(+56.7%) | $14.59 B(+6.2%) |
| Mar 2020 | - | $2.53 B(-28.6%) | $13.74 B(+0.9%) |
| Dec 2019 | $13.63 B(-4.5%) | $3.54 B(-22.4%) | $13.63 B(-1.6%) |
| Sept 2019 | - | $4.56 B(+46.6%) | $13.85 B(+3.8%) |
| June 2019 | - | $3.11 B(+29.0%) | $13.34 B(-5.9%) |
| Mar 2019 | - | $2.41 B(-36.0%) | $14.17 B(-0.7%) |
| Dec 2018 | $14.27 B(+13.1%) | $3.77 B(-7.0%) | $14.27 B(+2.6%) |
| Sept 2018 | - | $4.05 B(+2.7%) | $13.91 B(+3.4%) |
| June 2018 | - | $3.94 B(+56.8%) | $13.45 B(+2.8%) |
| Mar 2018 | - | $2.51 B(-26.2%) | $13.09 B(+3.7%) |
| Dec 2017 | $12.62 B(+10.0%) | $3.41 B(-5.0%) | $12.62 B(-1.4%) |
| Sept 2017 | - | $3.59 B(+0.1%) | $12.80 B(+2.9%) |
| June 2017 | - | $3.58 B(+75.2%) | $12.45 B(+3.9%) |
| Mar 2017 | - | $2.04 B(-43.1%) | $11.98 B(+4.4%) |
| Dec 2016 | $11.47 B(-3.5%) | $3.59 B(+11.1%) | $11.47 B(-4.7%) |
| Sept 2016 | - | $3.23 B(+3.9%) | $12.04 B(+0.9%) |
| June 2016 | - | $3.11 B(+101.8%) | $11.94 B(+1.7%) |
| Mar 2016 | - | $1.54 B(-62.9%) | $11.73 B(-1.4%) |
| Dec 2015 | $11.90 B(-14.4%) | $4.16 B(+33.0%) | $11.90 B(-8.1%) |
| Sept 2015 | - | $3.13 B(+7.4%) | $12.95 B(-6.4%) |
| June 2015 | - | $2.91 B(+70.8%) | $13.83 B(-3.0%) |
| Mar 2015 | - | $1.70 B(-67.3%) | $14.26 B(+2.6%) |
| Dec 2014 | $13.90 B(+5.5%) | $5.21 B(+29.8%) | $13.90 B(+5.7%) |
| Sept 2014 | - | $4.01 B(+20.1%) | $13.14 B(-2.7%) |
| June 2014 | - | $3.34 B(+149.1%) | $13.51 B(+6.5%) |
| Mar 2014 | - | $1.34 B(-69.9%) | $12.69 B(-3.7%) |
| Dec 2013 | $13.17 B | $4.45 B(+1.6%) | $13.17 B(-1.3%) |
| Sept 2013 | - | $4.38 B(+74.0%) | $13.35 B(+2.4%) |
| June 2013 | - | $2.52 B(+37.7%) | $13.04 B(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $1.83 B(-60.5%) | $13.51 B(-4.8%) |
| Dec 2012 | $14.19 B(-0.8%) | $4.63 B(+13.8%) | $14.19 B(-0.7%) |
| Sept 2012 | - | $4.07 B(+36.2%) | $14.29 B(-1.2%) |
| June 2012 | - | $2.98 B(+18.6%) | $14.46 B(-3.1%) |
| Mar 2012 | - | $2.52 B(-46.7%) | $14.92 B(+4.3%) |
| Dec 2011 | $14.31 B(+1.7%) | $4.72 B(+11.5%) | $14.31 B(+1.0%) |
| Sept 2011 | - | $4.23 B(+22.9%) | $14.16 B(+7.7%) |
| June 2011 | - | $3.45 B(+80.7%) | $13.16 B(+3.9%) |
| Mar 2011 | - | $1.91 B(-58.3%) | $12.67 B(-10.0%) |
| Dec 2010 | $14.07 B(+15.4%) | $4.58 B(+41.8%) | $14.07 B(+0.8%) |
| Sept 2010 | - | $3.23 B(+9.2%) | $13.96 B(+0.5%) |
| June 2010 | - | $2.96 B(-10.6%) | $13.88 B(+2.5%) |
| Mar 2010 | - | $3.31 B(-26.0%) | $13.54 B(+11.1%) |
| Dec 2009 | $12.19 B(+24.8%) | $4.47 B(+41.6%) | $12.19 B(+11.5%) |
| Sept 2009 | - | $3.15 B(+20.5%) | $10.93 B(+1.2%) |
| June 2009 | - | $2.62 B(+34.1%) | $10.80 B(+8.2%) |
| Mar 2009 | - | $1.95 B(-39.0%) | $9.98 B(+2.2%) |
| Dec 2008 | $9.77 B(+6.1%) | $3.20 B(+6.0%) | $9.77 B(+531.1%) |
| Sept 2008 | - | $3.02 B(+67.9%) | $1.55 B(-82.2%) |
| June 2008 | - | $1.80 B(+3.5%) | $8.71 B(-1.1%) |
| Mar 2008 | - | $1.74 B(-134.7%) | $8.81 B(-4.3%) |
| Dec 2007 | $9.21 B(+10.9%) | -$5.02 B(-149.2%) | $9.21 B(-42.8%) |
| Sept 2007 | - | $10.19 B(+437.2%) | $16.09 B(+92.3%) |
| June 2007 | - | $1.90 B(-11.4%) | $8.37 B(+3.4%) |
| Mar 2007 | - | $2.14 B(+14.7%) | $8.09 B(-2.6%) |
| Dec 2006 | $8.30 B(+7.1%) | $1.87 B(-24.3%) | $8.30 B(-0.8%) |
| Sept 2006 | - | $2.46 B(+51.9%) | $8.37 B(-0.8%) |
| June 2006 | - | $1.62 B(-31.0%) | $8.44 B(+3.6%) |
| Mar 2006 | - | $2.35 B(+21.6%) | $8.14 B(+5.1%) |
| Dec 2005 | $7.75 B(+18.1%) | $1.94 B(-23.6%) | $7.75 B(+3.1%) |
| Sept 2005 | - | $2.53 B(+91.2%) | $7.51 B(+7.1%) |
| June 2005 | - | $1.32 B(-32.3%) | $7.02 B(-4.6%) |
| Mar 2005 | - | $1.96 B(+15.2%) | $7.36 B(+12.1%) |
| Dec 2004 | $6.56 B(+0.2%) | $1.70 B(-16.6%) | $6.56 B(-1.3%) |
| Sept 2004 | - | $2.04 B(+22.3%) | $6.65 B(+2.4%) |
| June 2004 | - | $1.67 B(+43.4%) | $6.49 B(+9.0%) |
| Mar 2004 | - | $1.16 B(-34.9%) | $5.96 B(-9.1%) |
| Dec 2003 | $6.55 B(+25.3%) | $1.79 B(-4.9%) | $6.55 B(+37.5%) |
| Sept 2003 | - | $1.88 B(+66.2%) | $4.77 B(+65.0%) |
| June 2003 | - | $1.13 B(-35.8%) | $2.89 B(+64.2%) |
| Mar 2003 | - | $1.76 B | $1.76 B |
| Dec 2002 | $5.23 B(+20.0%) | - | - |
| Dec 2001 | $4.36 B(-7.6%) | - | - |
| Dec 2000 | $4.72 B(+9.0%) | - | - |
| Dec 1999 | $4.33 B(+1.7%) | - | - |
| Dec 1998 | $4.25 B | - | - |
FAQ
- What is Novartis AG annual cash flow from operations?
- What is the all time high annual CFO for Novartis AG?
- What is Novartis AG annual CFO year-on-year change?
- What is Novartis AG quarterly cash flow from operations?
- What is the all time high quarterly CFO for Novartis AG?
- What is Novartis AG quarterly CFO year-on-year change?
- What is Novartis AG TTM cash flow from operations?
- What is the all time high TTM CFO for Novartis AG?
- What is Novartis AG TTM CFO year-on-year change?
What is Novartis AG annual cash flow from operations?
The current annual CFO of NVS is $14.46 B
What is the all time high annual CFO for Novartis AG?
Novartis AG all-time high annual cash flow from operations is $15.07 B
What is Novartis AG annual CFO year-on-year change?
Over the past year, NVS annual cash flow from operations has changed by +$222.00 M (+1.56%)
What is Novartis AG quarterly cash flow from operations?
The current quarterly CFO of NVS is $6.29 B
What is the all time high quarterly CFO for Novartis AG?
Novartis AG all-time high quarterly cash flow from operations is $10.19 B
What is Novartis AG quarterly CFO year-on-year change?
Over the past year, NVS quarterly cash flow from operations has changed by +$908.00 M (+16.88%)
What is Novartis AG TTM cash flow from operations?
The current TTM CFO of NVS is $15.97 B
What is the all time high TTM CFO for Novartis AG?
Novartis AG all-time high TTM cash flow from operations is $16.09 B
What is Novartis AG TTM CFO year-on-year change?
Over the past year, NVS TTM cash flow from operations has changed by -$49.00 M (-0.31%)